Get our news on your inbox! x

Remember me Forgot password

MercoPress, en Español

Montevideo, April 18th 2024 - 02:02 UTC

Tag: Anvisa

  • Friday, April 12th 2024 - 22:20 UTC

    Brazil accounts for nearly 70% of dengue cases in LatAm and Caribbean

    Still, Brazil has reduced the number of deaths in the current dengue epidemic from previous years

    According to a survey conducted by the Pan American Health Organization (PAHO), Brazil accounted for almost 70% of dengue cases in Latin America and the Caribbean, where some 4.6 million infections were confirmed this year, representing a 237% interannual increase, Agencia Brasil reported. PAHO is the arm of the World Health Organization (WHO) in the Americas.

    1 comment
  • Monday, April 1st 2024 - 19:54 UTC

    Brazilian VP down with Covid-19

    Alckmin was said to be doing well after showing mild symptoms of the malady

    Brazil's Vice President Geraldo Alckmin stayed at home Monday after being diagnosed with Covid-19, Agencia Brasil reported. Alckin is also Minister of Development, Industry, Trade, and Services.

  • Thursday, January 11th 2024 - 11:06 UTC

    Brazilian-developed vaccine against Covid-19 registered by Anvisa

    The recombinant Zalika vaccine is monovalent for the original SARS-CoV-2 virus

    The new vaccine against Covid-19 developed by the Brazilian company Zalika Farmacêutica has been entered into the National Health Surveillance Agency (Anvisa) this week, Agencia Brasil reported. The drug can be used in people aged 12 and over and is to be administered in two doses, 21 days apart, with boosters after 6 months for those over 18 years of age.

  • Saturday, November 26th 2022 - 10:12 UTC

    Brazilian-developed COVID-19 vax begins clinical trials

    After the first two phases, a report will be sent to the National Health Surveillance Agency (Anvisa) for authorization of the next phase.

    Volunteers were given Friday their first injections of SpiN-Tec MCTI UFMG, a vaccine against COVID-19 developed in Brazil “with national technology and inputs” and “financed with resources from Brazilian institutions,” according to Agencia Brasil.

  • Wednesday, November 23rd 2022 - 18:30 UTC

    Brazil back to mandatory facemasks on airplanes and at airports

    The new regulations become effective Nov. 25

    Brazil's National Health Surveillance Agency (Anvisa) Wednesday approved the return effective Nov. 25 of the mandatory use of face masks in airplanes and airports in a move to reduce the risk of COVID-19 contagion after a significant increase in the number of cases in recent weeks.

  • Friday, August 26th 2022 - 17:46 UTC

    Brazil greenlights import of vaccine, drug against monkeypox

    The decisions were based on reports from the FDA, EMA, and NHS

    Brazil's National Health Surveillance Agency (Anvisa) Thursday cleared the Health Ministry in separate but unanimous decisions to import and use the Jynneos / Imvanex vaccine and the drug Tecovirimat, both against monkeypox.

  • Thursday, August 18th 2022 - 20:52 UTC

    Brazil's Anvisa signals end of mandatory facemasks in airplanes

    Masks at air terminals and on airplanes are no longer required in several countries

    Brazil's National Health Surveillance Agency (Anvisa) has agreed to end the mandatory wearing of facemasks on airplanes, which will be henceforth just “recommended,” it was reported. The measure will become effective as soon as it is published in the Official Gazette.

  • Tuesday, August 16th 2022 - 20:30 UTC

    Brazilian port of Santos handles growing volumes of trade

    The quarterly net profit totaled R$ 144.8 million (US$ 28.17 million), a 46.4% improvement from the second quarter of 2021

    The state-owned Santos Port Authority (SPA) reported over the weekend that volumes handled through the largest seaport in Brazil grew 2.3% between April and June of 2022, reaching 42 million tons of goods.

  • Saturday, July 23rd 2022 - 10:29 UTC

    Anvisa still waiting for Pfizer's reply regarding their covid-19 vaccine

    Anvisa gave Pfizer 120 days to submit information to decide whether the benefits of the vaccine outweigh the risks

    Brazil's National Health Surveillance Agency (Anvisa) has requested some additional information from Wyeth/Pfizer regarding booster doses of their COVID-19 vaccine for children and adolescents and is still waiting for a reply, Agencia Brasil reported Friday.

  • Thursday, June 9th 2022 - 09:34 UTC

    First case of monkeypox confirmed in Brazil

    Anvisa has recommended a return to COVID-19 sanitary precautions

    A 41-year-old man from São Paulo who had just returned from Spain has been confirmed Wednesday as Brazil's first case of monkeypox. The patient is now in isolation at the Emilio Ribas Hospital in South America's largest city, which is also monitoring a 26-year-old woman, also in isolation, but with no travel record.

Previous